Pharmaceuticals

Orthopedic devices major Stryker Corp (SYK) has raised its quarterly dividend to 18 cents a share from 15 cents, representing a 20% hike. This lifts the annual dividend to 72 cents per share from the current payout of 60 cents and equates to a dividend yield of roughly 1.4%. The revised quarterly...

Cusick's Corner There are relationships that you watch -- bonds & equities, strength in offensive sectors, XLF, that help traders and investors position. While these relationships often change, faster than my wife's mind about whether she still likes me or not, they are important to watch....

California-based diagnostic products maker Gen-Probe Inc (GPRO) hassecured approval from the U.S. Food and Drug Administration (FDA) for its Prodesse ProAdeno+ assay for the detection of human adenovirus infection. The assay represents the latest addition to the company's Prodesse line of...

Orthopedic devices major Stryker Corp (SYK) has raised its quarterly dividend to 18 cents a share from 15 cents, representing a 20% hike. This lifts the annual dividend to 72 cents per share from the current payout of 60 cents and equates to a dividend yield of roughly 1.4%. The revised quarterly...

Biodel (NASDAQ: BIOD) today reported financial results for the fourth quarter and fiscal year ended September 30, 2010. Fourth Quarter and Fiscal Year 2010 Financial Results Biodel reported a net loss for the quarter ended September 30, 2010 of $8.1 million, or $0.31 per share, compared to a net...

We recently reiterated our Outperform recommendation on The Medicines Company (MDCO). In August 2010, The Medicines Company received good news with the US District Court for the Eastern District of Virginia ordering the US Patent and Trademark Office (PTO) to treat The Medicines Company's patent...

We recently reiterated our Outperform recommendation on The Medicines Company (MDCO). In August 2010, The Medicines Company received good news with the US District Court for the Eastern District of Virginia ordering the US Patent and Trademark Office (PTO) to treat The Medicines Company's patent...

Cusick's Corner In an effort to increase interest in our daily market commentary to those who had lost contact, we sent an email to more people than we intended on December 9, 2010. We apologize for any inconvenience that this may have caused. If you get and read Xpound already, you will still get...

Shares of Smith & Wesson Holdings Corp (NASDAQ: SWHC) declined about 4.45% after the company reported quarterly results. SWHC reported a FQ2 net loss of $0.62 per share, versus net earnings of $0.22 per share, in the year-earlier period. Excluding one-time items, SWHC posted earnings at $0.05...

Vivus Inc. (VVUS) recently reported positive late-stage data on its erectile dysfunction (ED) candidate, avanafil. The phase III trial (TA-314) met all the primary endpoints and also confirmed the long-term safety and efficacy of the potential drug, as observed in the earlier placebo-controlled...

Recently, Shire Plc. (SHPGY) received a boost when Health Canada approved Vpriv (velaglucerase alfa), its drug for Gaucher disease, for pediatric and adult patients. The approval was based on a large clinical program conducted at 24 sites in 10 countries. Over 100 patients participated in the...

Vivus Inc. (VVUS) recently reported positive late-stage data on its erectile dysfunction (ED) candidate, avanafil. The phase III trial (TA-314) met all the primary endpoints and also confirmed the long-term safety and efficacy of the potential drug, as observed in the earlier placebo-controlled...

Alkermes Inc.'s (ALKS) pipeline received a boost with its candidate ALKS 33 faring well in a mid-stage study (n=400) in alcohol dependent patients. The candidate is being developed for treating patients suffering from reward disorders and other central nervous system (CNS) problems.  The study...

Recently, Shire Plc. (SHPGY) received a boost when Health Canada approved Vpriv (velaglucerase alfa), its drug for Gaucher disease, for pediatric and adult patients. The approval was based on a large clinical program conducted at 24 sites in 10 countries. Over 100 patients participated in the...

Everyone would like to have a passive income stream. Passive income can help to supplement your existing income. The great thing about a passive income stream is that it is income that you do not work for on a full time day to day basis. Passive income is defined as income that you earn from...